Quest Diagnostics (DGX) Peer Comparison
$258.28
As on 20-Nov-2026 16:01EST
Market cap
$28,416 Mln
Revenue (TTM)
$11,841 Mln
P/E Ratio
25.7
P/B Ratio
3.7
Div. Yield
1.3 %
| Quest Diagnostics (DGX) | CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Natera (NTRA) | Labcorp Holdings | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
28,416 | 102,409 | 96,159 | 46,269 | 29,951 |
Revenue ($ Mln) |
11,841 | 420,614 | 78,701 | 2,909 | 14,595 |
Net Profit ($ Mln) |
1,129.00 | 11,053.00 | 6,776.00 | -164.71 | 1,004.00 |
Net Margin (%) |
9.53 | 2.63 | 8.61 | -5.66 | 6.88 |
RoE (%) |
14.38 | 13.98 | -- | -9.04 | 11.41 |
Price to Earnings |
25.73 | 9.30 | 15.80 | -- | 30.23 |
Price-To-Book |
3.73 | 1.29 | 291.34 | 25.05 | 2.94 |
Income Statement ($ Mln)
| Quest Diagnostics (DGX) | CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Natera (NTRA) | Labcorp Holdings | |
|---|---|---|---|---|---|
|
Operating Revenue
|
11,841.00 | 420,614.00 | 78,701.00 | 2,908.88 | 14,594.50 |
|
Cost of Revenue
|
7,920.00 | 360,776.00 | 61,631.00 | 1,011.95 | 10,367.40 |
|
Gross Profit
|
3,665.00 | 55,362.00 | 31,374.00 | 1,495.49 | 4,012.50 |
|
Operating Expenses
|
2,198.00 | 44,777.00 | 55,312.00 | 2,157.34 | 2,725.00 |
|
Operating Profit (EBIT)
|
1,723.00 | 15,061.00 | 12,072.00 | -260.42 | 1,502.10 |
|
Other Income
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
1,499.00 | 12,118.00 | 9,823.00 | -224.98 | 1,224.70 |
|
Provision for Tax
|
342.00 | 1,086.00 | 2,024.00 | -60.26 | 219.60 |
|
Profit after Tax (Net Income)
|
1,129.00 | 11,053.00 | 6,776.00 | -164.71 | 1,004.00 |
|
Minority Interest
|
-51.00 | -9.00 | -1,023.00 | 0.00 | -1.10 |
|
Consolidated Profit
|
245.00 | 2,943.00 | 1,878.00 | 0.00 | 164.70 |
Liabilities ($ Mln)
| Quest Diagnostics (DGX) | CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Natera (NTRA) | Labcorp Holdings | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
7,632.00 | 80,497.00 | -8,077.00 | 1,869.56 | 8,847.80 |
|
Minority Interest
|
-51.00 | -9.00 | -1,023.00 | 0.00 | -1.10 |
|
Non-Current Liabilities
|
7,356.00 | 84,289.00 | 48,272.00 | 265.96 | 7,241.10 |
|
Current Liabilities
|
1,834.00 | 93,097.00 | 19,779.00 | 612.90 | 2,819.60 |
|
Total Liabilities
|
16,225.00 | 253,538.00 | 60,720.00 | 2,398.34 | 18,392.70 |
Assets ($ Mln)
| Quest Diagnostics (DGX) | CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Natera (NTRA) | Labcorp Holdings | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
14,104.00 | 178,683.00 | 47,233.00 | 1,025.80 | 14,958.40 |
|
Current Assets
|
3,117.00 | 79,392.00 | 16,219.00 | 1,722.61 | 3,966.20 |
|
Total Assets
|
16,225.00 | 253,538.00 | 60,720.00 | 2,398.34 | 18,392.70 |
|
Total Debt*
|
6,285.00 | 75,297.00 | 52,426.00 | 238.84 | 6,775.90 |
|
Net Current Assets
|
1,283.00 | -13,705.00 | -3,560.00 | 1,109.72 | 1,146.60 |
Cashflow ($ Mln)
| Quest Diagnostics (DGX) | CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Natera (NTRA) | Labcorp Holdings | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
1,886.00 | 10,639.00 | 12,636.00 | 215.30 | 1,640.50 |
|
Cash Flow from Investing Activities
|
-631.00 | -5,871.00 | -4,988.00 | -132.21 | -1,194.00 |
|
Cash from Financing Activities
|
-1,388.00 | -4,940.00 | -8,550.00 | 47.46 | -1,457.00 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Quest Diagnostics (DGX) | CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Natera (NTRA) | Labcorp Holdings | |
|---|---|---|---|---|---|
|
ROCE (%)
|
7.10 | 1.13 | 14.79 | -12.58 | 5.75 |
|
ROE (%)
|
14.38 | 13.98 | -612.27 | -9.04 | 11.41 |
|
ROA (%)
|
6.04 | 3.16 | 8.42 | -5.86 | 4.71 |
|
EBIT Margin (%)
|
14.51 | 3.61 | 15.45 | -7.46 | 9.93 |
|
Net Margin (%)
|
9.53 | 2.63 | 8.61 | -5.66 | 6.88 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Quest Diagnostics (DGX) | CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Natera (NTRA) | Labcorp Holdings | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
9.13 | 6.73 | 5.82 | 37.43 | 6.02 |
|
EBIT Growth (%)
|
8.87 | 153.30 | 5.76 | 29.00 | 8.72 |
|
Net Profit Growth (%)
|
16.51 | 2,256.72 | 6.81 | 46.73 | 17.40 |
|
EPS Growth (%)
|
17.55 | 2,152.97 | 17.46 | 50.61 | 19.83 |
|
Book Value Growth (%)
|
6.09 | 8.50 | -317.59 | 42.17 | 4.35 |
Valuation Ratios
| Quest Diagnostics (DGX) | CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Natera (NTRA) | Labcorp Holdings | |
|---|---|---|---|---|---|
|
Price / Earnings
|
19.59 | 57.32 | 15.88 | -150.47 | 23.81 |
|
Price / Book Value
|
3.73 | 1.29 | 291.34 | 18.29 | 2.94 |
|
Dividend Yield (%)
|
1.30 | 3.27 | 0.64 | -- | 0.78 |
|
EV/EBITDA
|
15.16 | 8.72 | 9.05 | -138.12 | 16.66 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Quest Diagnostics (DGX) | CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Natera (NTRA) | Labcorp Holdings | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.73 | 0.71 | -5.25 | 0.00 | 0.59 |
|
Short term debt to equity ratio
|
0.03 | 0.07 | -1.00 | 0.05 | 0.09 |
|
Current Ratio
|
1.70 | 0.85 | 0.82 | 2.81 | 1.41 |
|
Quick Ratio
|
1.58 | 0.66 | 0.74 | 2.66 | 1.22 |
|
Interest Coverage
|
6.90 | 4.95 | 5.16 | -21.88 | 6.32 |
Operating Efficiency Ratios
| Quest Diagnostics (DGX) | CVS Health Corp (CVS) | HCA Holdings Inc (HCA) | Natera (NTRA) | Labcorp Holdings | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
14.46 | 10.00 | 14.62 | 16.20 | 17.53 |
|
Asset Turnover
|
0.63 | 1.20 | 0.98 | 1.03 | 0.68 |
|
Receivable days
|
44.88 | 34.63 | 52.22 | 48.36 | 57.04 |
|
Inventory Days
|
9.34 | 19.68 | 14.00 | 25.50 | 18.89 |
|
Payable days
|
46.76 | 17.66 | 36.90 | 15.34 | 31.54 |
|
Cash Conversion Cycle
|
7.47 | 36.65 | 29.32 | 58.52 | 44.39 |